Protagenic Therapeutics (PTIX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.73 (-13.10%), Market cap $0.00B, 52-week low–high $0.35 ~ $11.10.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
Financial statements, price targets, institutional (13F) holdings and related news for Protagenic Therapeutics are updated in real time on BlackAll Trade.
Protagenic Therapeutics trades at $0.73 (-13.10%). Real-time quotes and charts are available on BlackAll Trade.
Protagenic Therapeutics has a market cap of about $0.00B.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, I